Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO2017136330) EXTENDED RELEASE FORMULATIONS OF VELIPARIB FOR THE TREATMENT OF CANCER
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2017/136330 International Application No.: PCT/US2017/015792
Publication Date: 10.08.2017 International Filing Date: 31.01.2017
IPC:
A61K 31/4184 (2006.01) ,A61K 9/00 (2006.01) ,A61P 35/00 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
41
having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
4164
1,3-Diazoles
4184
condensed with carbocyclic rings, e.g. benzimidazoles
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35
Antineoplastic agents
Applicants:
ABBVIE INC. [US/US]; 1 North Waukegan Road North Chicago, Illinois 60064, US
Inventors:
XIONG, Hao; US
DEBORD, Alyssa E.; US
KOMARNITSKY, Philip; US
NUTHALAPATI, Silpa; US
STODTMANN, Sven; DE
Agent:
SUN, Changxia; US
AHMED, Aamer; US
BAUDE, Eric J.; US
CHEN, Portia; US
CORBIN, Johanna; US
GESICKI, Glen J.; US
JOHANNES, Laura; US
KAMPS, Matthew M.; US
STEELE, Gregory W.; US
WARD, Michael J.; US
ZHANG, Xu; US
Priority Data:
62/289,80801.02.2016US
Title (EN) EXTENDED RELEASE FORMULATIONS OF VELIPARIB FOR THE TREATMENT OF CANCER
(FR) FORMULATIONS À LIBÉRATION PROLONGÉE DE VÉLIPARIB POUR LE TRAITEMENT DU CANCER
Abstract:
(EN) Described herein are extended release formulations of veliparib, ways to make them, and methods of treating cancer using them.
(FR) L'invention concerne des formulations à libération prolongée de véliparib, des procédés de fabrication de celles-ci et des procédés de traitement du cancer utilisant celles-ci.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
EP3411027US20190029951